Search Results - "Bovinder Ylitalo, Erik"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival by Hörnberg, Emma, Ylitalo, Erik Bovinder, Crnalic, Sead, Antti, Henrik, Stattin, Pär, Widmark, Anders, Bergh, Anders, Wikström, Pernilla

    Published in PloS one (28-04-2011)
    “…Constitutively active androgen receptor variants (AR-V) lacking the ligand binding domain (LBD) may promote the development of castration-resistant prostate…”
    Get full text
    Journal Article
  2. 2

    KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus by Lundwall, Åke, Ylitalo, Erik Bovinder, Wikström, Pernilla, Brattsand, Maria

    “…The human kallikrein-related peptidase 4 (KLK4) and the transcribed pseudogene KLKP1 are reported to be highly expressed in the prostate. When trying to clone…”
    Get full text
    Journal Article
  3. 3

    Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants by Jernberg, Emma, Thysell, Elin, Bovinder Ylitalo, Erik, Rudolfsson, Stina, Crnalic, Sead, Widmark, Anders, Bergh, Anders, Wikström, Pernilla

    Published in PloS one (07-11-2013)
    “…Intra-tumoral steroidogenesis and constitutive androgen receptor (AR) activity have been associated with castration-resistant prostate cancer (CRPC). This…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens by Ylitalo, Erik Bovinder, Thysell, Elin, Thellenberg‐Karlsson, Camilla, Lundholm, Marie, Widmark, Anders, Bergh, Anders, Josefsson, Andreas, Brattsand, Maria, Wikström, Pernilla

    Published in The Prostate (01-02-2020)
    “…Background Taxane treatment may be a suitable therapeutic option for patients with castration‐resistant prostate cancer and high expression of constitutively…”
    Get full text
    Journal Article
  6. 6

    Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity by Nordstrand, Annika, Bovinder Ylitalo, Erik, Thysell, Elin, Jernberg, Emma, Crnalic, Sead, Widmark, Anders, Bergh, Anders, Lerner, Ulf H, Wikström, Pernilla

    “…Advanced prostate cancer frequently metastasizes to bone and induces a mixed osteoblastic/osteolytic bone response. Standard treatment for metastatic prostate…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response by Ylitalo, Erik Bovinder, Thysell, Elin, Jernberg, Emma, Lundholm, Marie, Crnalic, Sead, Egevad, Lars, Stattin, Pär, Widmark, Anders, Bergh, Anders, Wikström, Pernilla

    Published in European urology (01-05-2017)
    “…Abstract Background Novel therapies for men with castration-resistant prostate cancer (CRPC) are needed, particularly for cancers not driven by androgen…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer by Ylitalo, Erik Bovinder, Thysell, Elin, Landfors, Mattias, Brattsand, Maria, Jernberg, Emma, Crnalic, Sead, Widmark, Anders, Hultdin, Magnus, Bergh, Anders, Degerman, Sofie, Wikström, Pernilla

    Published in Clinical epigenetics (30-06-2021)
    “…Patients with metastatic prostate cancer (PC) are treated with androgen deprivation therapy (ADT) that initially reduces metastasis growth, but after some time…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328 by Järemo, Helena, Semenas, Julius, Bergström, Sofia Halin, Lundholm, Marie, Thysell, Elin, Widmark, Anders, Crnalic, Sead, Ylitalo, Erik Bovinder, Bergh, Anders, Brattsand, Maria, Wikström, Pernilla

    Published in Cancers (24-04-2023)
    “…MicroRNAs (miRNAs) are aberrantly expressed in prostate cancer (PC), but comprehensive knowledge about their levels and function in metastatic PC is lacking…”
    Get full text
    Journal Article
  13. 13

    Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone by Nordstrand, Annika, Bergström, Sofia Halin, Thysell, Elin, Bovinder-Ylitalo, Erik, Lerner, Ulf H., Widmark, Anders, Bergh, Anders, Wikström, Pernilla

    Published in Clinical & experimental metastasis (01-04-2017)
    “…Prostate cancer (PCa) patients with bone metastases are primarily treated with androgen deprivation therapy (ADT). Less pronounced ADT effects are seen in…”
    Get full text
    Journal Article
  14. 14

    Abstract 1332: Extracted mRNA from frozen buffy coat samples shows promise for use in downstream sequencing analyses by Ylitalo, Erik Bovinder, Vidman, Linda, Harlid, Sophia, Van Guelpen, Bethany

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Frozen blood samples are routinely collected and stored in medical biobanks across the world, often for periods of several decades, and later used for medical…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Abstract A048: Bone remodeling in relation to androgen receptor activity in prostate cancer bone metastases by Ylitalo, Erik Bovinder, Nordstrand, Annika, Thysell, Elin, Jernberg, Emma, Crnalic, Sead, Widmark, Anders, Bergh, Anders, Lerner, Ulf H., Wikström, Pernilla

    Published in Cancer research (Chicago, Ill.) (15-08-2018)
    “…Prostate cancer often metastasizes to bone and the metastases are generally classified as osteoblastic, although a mixed osteoblastic/osteolytic bone response…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19